These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25451732)

  • 21. Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Toomey P; Childs C; Luberice K; Ross S; Rosemurgy A
    Am Surg; 2013 Aug; 79(8):781-5. PubMed ID: 23896244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for adenocarcinoma of the head of the pancreas.
    Yang YM; Wan YL; Tian XD; Zhuang Y; Huang YT
    Chin Med J (Engl); 2005 Nov; 118(22):1863-9. PubMed ID: 16313840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and Oncological Implications of Previously Undetected Tumor Multicentricity Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in Patients Undergoing Salvage Pancreatectomy.
    Andreou A; Klein F; Schmuck RB; Lee D; Sinn M; Denecke T; Pratschke J; Bahra M
    Anticancer Res; 2017 Sep; 37(9):5269-5275. PubMed ID: 28870964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium.
    Kelly KN; Macedo FI; Seaton M; Wilson G; Hammill C; Martin RC; Maduekwe UN; Kim HJ; Maithel SK; Abbott DE; Ahmad SA; Kooby DA; Merchant NB; Datta J
    Ann Surg Oncol; 2022 Sep; 29(9):6004-6012. PubMed ID: 35511392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome after pancreaticoduodenectomy for T3 adenocarcinoma: A multivariable analysis from the UK Vascular Resection for Pancreatic Cancer Study Group.
    Elberm H; Ravikumar R; Sabin C; Abu Hilal M; Al-Hilli A; Aroori S; Bond-Smith G; Bramhall S; Coldham C; Hammond J; Hutchins R; Imber C; Preziosi G; Saleh A; Silva M; Simpson J; Spoletini G; Stell D; Terrace J; White S; Wigmore S; Fusai G
    Eur J Surg Oncol; 2015 Nov; 41(11):1500-7. PubMed ID: 26346183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving results of pancreaticoduodenectomy for pancreatic cancer.
    Yeo CJ; Cameron JL
    World J Surg; 1999 Sep; 23(9):907-12. PubMed ID: 10449819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should pancreaticoduodenectomy be performed in octogenarians?
    Sohn TA; Yeo CJ; Cameron JL; Lillemoe KD; Talamini MA; Hruban RH; Sauter PK; Coleman J; Ord SE; Grochow LB; Abrams RA; Pitt HA
    J Gastrointest Surg; 1998; 2(3):207-16. PubMed ID: 9841976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreaticogastrostomy: A Safe Option in Pancreaticoduodenectomy for Pancreatic Head and Periampullary Neoplasms.
    Noor MA; Hanif F; Shakeel O; Bari H
    J Coll Physicians Surg Pak; 2020 Jan; 30(1):51-56. PubMed ID: 31931933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Gaujoux S; Torres J; Olson S; Winston C; Gonen M; Brennan MF; Klimstra DS; D'Angelica M; DeMatteo R; Fong Y; House M; Jarnagin W; Kurtz RC; Allen PJ
    Ann Surg Oncol; 2012 Sep; 19(9):2908-16. PubMed ID: 22411205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic adenocarcinoma: complete tumor extirpation improves survival benefit despite larger tumors for patients who undergo distal pancreatectomy and splenectomy.
    Toomey P; Hernandez J; Golkar F; Ross S; Luberice K; Rosemurgy A
    J Gastrointest Surg; 2012 Feb; 16(2):376-81. PubMed ID: 22135126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival.
    Reddy S; Wolfgang CL; Cameron JL; Eckhauser F; Choti MA; Schulick RD; Edil BH; Pawlik TM
    Ann Surg; 2009 Aug; 250(2):282-7. PubMed ID: 19638918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.
    Jamieson NB; Denley SM; Logue J; MacKenzie DJ; Foulis AK; Dickson EJ; Imrie CW; Carter R; McKay CJ; McMillan DC
    Ann Surg Oncol; 2011 Aug; 18(8):2318-28. PubMed ID: 21267785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreaticoduodenectomy after neoadjuvant therapy in a Jehovah's witness with locally advanced pancreatic cancer: case report and approach to avoid transfusion.
    Magner D; Ouellette JR; Lee JR; Colquhoun S; Lo S; Nissen NN
    Am Surg; 2006 May; 72(5):435-7. PubMed ID: 16719200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and oncologic efficacy of robotic compared to open pancreaticoduodenectomy after neoadjuvant chemotherapy for pancreatic cancer.
    Nassour I; Tohme S; Hoehn R; Adam MA; Zureikat AH; Alessandro P
    Surg Endosc; 2021 May; 35(5):2248-2254. PubMed ID: 32440928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumour of the pancreas.
    Yeh JJ; Gonen M; Tomlinson JS; Idrees K; Brennan MF; Fong Y
    Br J Surg; 2007 Apr; 94(4):466-72. PubMed ID: 17330243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical morbidity, mortality, and long-term survival in patients with peripancreatic cancer following pancreaticoduodenectomy.
    Stephens J; Kuhn J; O'Brien J; Preskitt J; Derrick H; Fisher T; Fuller R; Lieberman Z
    Am J Surg; 1997 Dec; 174(6):600-3; discussion 603-4. PubMed ID: 9409581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic versus open pancreaticoduodenectomy for pancreatic adenocarcinoma: long-term results at a single institution.
    Stauffer JA; Coppola A; Villacreses D; Mody K; Johnson E; Li Z; Asbun HJ
    Surg Endosc; 2017 May; 31(5):2233-2241. PubMed ID: 27604369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile.
    Toomey P; Hernandez J; Morton C; Duce L; Farrior T; Villadolid D; Ross S; Rosemurgy A
    Am Surg; 2009 Sep; 75(9):804-9; discussion 809-10. PubMed ID: 19774952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in presentation and perioperative outcome after pancreaticoduodenectomy for cancer and benign pancreatitis.
    Chu CK; Sarmiento JM; Park J; Staley CA; Galloway JR; Adsay NV; Kooby DA
    Am Surg; 2010 Jun; 76(6):606-13. PubMed ID: 20583516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.